RADIOLOGICAL AND PATHOLOGICAL CORRELATION OF LUNG NODULES IN A BACKGROUND OF METASTATIC DISEASE
Abstract
Background: Computed tomography (CT) imaging has improved the chances of detecting small indeterminate (<1 cm) lung nodules. The determination of the underlying malignant or benign nature of a lung nodule poses a great diagnostic challenge and depends on a number of factors, including the radiographic appearance of nodule, the presence of non-pulmonary metastases, characteristics of growth and histological criteria.
Methods: The medical records of 89 patients admitted to our specialist cancer centre between 2008 and 2013 were reviewed. Patients of all age groups and tumour category were included in the study. Clinical data of these patients were collected and the following parameters were analysed: Radiographic diagnosis, location, size, laterality and number of nodules and histological impression. The radiological findings were then correlated with histopathological findings. The nodules were sub-classified into groups on the basis of size (A = 0–0.5 cm; B = 0.5–0.9 cm; C = 1.0–1.5 cm and D = >1.5 cm).
Results: CT scan reports of 89 patients with lung nodules were reviewed. On radiology, 73/89 (82%) were reported to be malignant nodule. Histopathological review of the biopsies of these 89 nodules confirmed malignancy in 50/89 (56.2%) patients. CT scan was found to be highly sensitive (94%, 95% confidence interval [CI]: 83.43–98.68%) but with a very low specificity (33.3%, 95% CI: 19.10–50.22%). CT scan was found to have a higher negative predictive value (81.2%, 95% CI: 54.34–95.73%) and a lower positive predictive value 64.4% (95% CI: 52.31–75.25%) when correlated with histopathological findings. Pathology of these nodules included metastatic sarcoma (27/89; 30.3%) and carcinoma (18/89; 20.2%). The frequency of the biopsy-proven malignant nodules on the right side was 26/45 (57.8%) and on the left side was 24/44 (54.5%) (P = 0.832). Malignant nodules were more frequent in lower lobes (28/43, 65.1%) than in upper lobes (14/32, 43.8%). These two sites combined accounted for 84% of all malignant nodules. There was a significant correlation between nodule size and likelihood of underlying malignancy. The overall prevalence of malignancy in the larger nodules (C and D) was much higher (23/30 and 76.7%) compared to the smaller sized (A and B) nodules (27/58 and 46.8%), P < 0.05.
Conclusion: CT scan is a useful tool in the initial clinical assessment of indeterminate lung nodules with high sensitivity (94%) and a high negative predictive value (81.2%).
Key words: Computed tomography, fibrosis, indeterminate lung nodule, infection, lung nodule, malignancy, metastases
References
McCarville MB, Lederman HM, Santana VM, et al. Distinguishing benign from malignant pulmonary nodules with helical chest CT in children with malignant solid tumors. Radiology 2006;239:514-20.
Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001;12:1601-4.
Wilimas JA, Douglass EC, Magill HL, et al. Signi cance of pulmonary computed tomography at diagnosis in Wilms’ tumour. J Clin Oncol 1988;6:1144-6.
Libby DM, Smith JP, Altorki NK., Managing the small pulmonary nodule discovered by CT. Chest 2004;125: 1522-9.
Munden RF, Hess KR. “Ditzels” on chest CT: Survey of members of the society of thoracic radiology. AJR Am J Roentgenol 2001;176:1363-9.
Mulshine JL. New developments in lung cancer screening. J Clin Oncol 2005;23:3198-202.
Heuvelmans MA, Oudkerk M, de Jong PA, et al. The impact of radiologists’ expertise on screen results decisions in a CT lung cancer screening trial. Eur Radiol 2015;25:792-9.
Carillo GA, Vázquez JE, Villar AF. Prevalence of benign pulmonary lesions excised for suspicion of malignancy: Could it re ect a quality management index of indeterminate lung lesions? Korean J Thorac Cardiovasc Surg 2014;47:458-64.
Gierada DS, Pinsky P, Nath H, et al. Projected outcomes using different nodule sizes to de ne a positive CT lung cancer screening examination. J Natl Cancer Inst 2014; 106:284.
Siegelman SS, Khouri NF, Leo FP, et al. Solitary pulmonary nodules: CT assessment. Radiology 1986;160:307-12.
Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodule: A cooperative study. Radiology 1986;160: 319-27.
Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776 90.
Kaste SC, Pratt CB, Cain AM, et al. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: Imaging features. Cancer 1999;86: 1602-8.
Pappo AS, Rao BN, Jenkins JJ, et al. Metastatic non rhabdomyosarcomatous soft-tissue negative predictive value (81.2%) experience. Med Pediatr Oncol 1999;33:76-82.
Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: The Japanese musculoskeletal oncology group study. J Clin Oncol 2002;20: 3470-7.
Green DM, Fernbach DJ, Norkool P, et al. The treatment of Wilms’ tumour patients with pulmonary metastases detected only with computed tomography: A report from the national Wilms’ tumour study. J Clin Oncol 1991;9:1776-81.
Owens CM, Veys PA, Pritchard J, et al. Role of chest computed tomography at diagnosis in the management of Wilms’ tumor: A study by the United Kingdom children’s cancer study group. J Clin Oncol 2002;20:2768-73.
Daw NC, Billups CA, Rodriguez-Galindo C, et al. Metastatic osteosarcoma. Cancer 2006;106:403-12.
Harris MB, Gieser P, Goorin AM, et al. Treatment of metastatic osteosarcoma at diagnosis: A Pediatric oncology group study. J Clin Oncol 1998;16:3641-8.
Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2003;21:2011-8.
Meyer WH, Schell MJ, Kumar AP, et al. Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic
indicators of survival. Cancer 1987;59:374-9.
Meyers PA, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993;11:449-53.
Putnam JB Jr., Roth JA, Wesley MN, et al. Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: Analysis of prognostic factors. Ann Thorac Surg 1983;36:516-23.
Roth JA, Putnam JB Jr., Wesley MN, et al. Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients. Cancer 1985;55:1361-6.
Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-13.
Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: Suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164-8.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.
Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.
